Nanomix Inc. is developing a rapid, mobile, point-of-care assay for the SARS-CoV-2 virus with the assistance of the US government.
The Emeryville, CA-based company is developing the Nanomix COVID-19 assay for its portable eLab analyzer for hospitals, nursing homes, assisted...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?